These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26760586)

  • 21. Managing acute promyelocytic leukemia without conventional chemotherapy: is it possible?
    Park JH; Tallman MS
    Expert Rev Hematol; 2011 Aug; 4(4):427-36. PubMed ID: 21801134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia.
    Jillella AP; Kota VK
    Blood Rev; 2018 Mar; 32(2):89-95. PubMed ID: 29033137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemostatic problems in acute promyelocytic leukaemia.
    Arbuthnot C; Wilde JT
    Blood Rev; 2006 Nov; 20(6):289-97. PubMed ID: 16757074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.
    Iland HJ; Wei A; Seymour JF
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):39-52. PubMed ID: 24907016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute promyelocytic leukemia: recent advances in diagnosis and management.
    Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
    Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute promyelocytic leukemia with asymptomatic cerebral hemorrhage].
    Koi S; Nogami A; Fujiwara H; Bando K; Saito M; Osada Y; Tanaka K; Sakashita C; Yoshifuji K; Okada K; Umezawa Y; Nagao T; Yamamoto M; Mori T
    Rinsho Ketsueki; 2023; 64(11):1426-1430. PubMed ID: 38072429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Devil with angel wings - when vitamin A saves lives].
    Benoit TM; Gundermann S
    Dtsch Med Wochenschr; 2023 Mar; 148(7):396-399. PubMed ID: 36940690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.
    Ma G; Liu F; Lv L; Gao Y; Su Y
    Ann Hematol; 2013 May; 92(5):645-52. PubMed ID: 23344645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
    Ventura GJ; Hester JP; Dixon DO; Khorana S; Keating MJ
    Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
    Bassan R; Battista R; Viero P; d'Emilio A; Buelli M; Montaldi A; Rambaldi A; Tremul L; Dini E; Barbui T
    Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors.
    Avvisati G; Lo Coco F; Mandelli F
    Semin Hematol; 2001 Jan; 38(1):4-12. PubMed ID: 11172535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute promyelocytic leukaemia in the all trans retinoic acid era.
    DeLoughery TG; Goodnight SH
    Med Oncol; 1996 Dec; 13(4):233-40. PubMed ID: 9152974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
    Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
    Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for early in-hospital death in patients who developed coagulopathy during induction therapy for acute promyelocytic leukemia: a nationwide analysis in Japan.
    Matsuda K; Jo T; Toyama K; Nakazaki K; Matsui H; Fushimi K; Yasunaga H; Kurokawa M
    Ann Hematol; 2021 Oct; 100(10):2613-2619. PubMed ID: 34308494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
    Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
    Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia.
    Breen KA; Grimwade D; Hunt BJ
    Br J Haematol; 2012 Jan; 156(1):24-36. PubMed ID: 22050876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term curative effects of sequential therapy with all-trans retinoic acid, arsenious oxide and chemotherapy on patients with acute promyelocytic leukemia.
    Pei R; Cao J; Ma J; Zhang P; Liu X; Du X; Chen D; Sha K; Chen L; Li S; Wu J; Fan Z; Lin L; Ye P; Tang S; Zhang B
    Hematology; 2012 Nov; 17(6):311-6. PubMed ID: 23168069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study.
    Zhao H; Sun J; Yan L; Jin B; Hou W; Cao F; Li H; Zhou J; Zhang Y
    Ann Hematol; 2021 Jun; 100(6):1473-1483. PubMed ID: 33893844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.